HCID 69630218, compound → HCID 9850545, compound
Reaction equation
[C:1]1([S:7]([NH:10][CH:11]([C:28](=[O:40])[NH:29][CH2:30][CH2:31][CH2:32][CH2:33][C:34]2[CH:39]=[CH:38][CH:37]=[CH:36][CH:35]=2)[CH2:12][C:13]2[CH:21]=[C:20](Cl)[C:19]([O:23][CH2:24][C:25]([OH:27])=[O:26])=[C:18]3[C:14]=2[CH:15]=[N:16][NH:17]3)(=[O:9])=[O:8])[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1>CO.[Pd]>[C:1]1([S:7]([NH:10][CH:11]([C:28](=[O:40])[NH:29][CH2:30][CH2:31][CH2:32][CH2:33][C:34]2[CH:35]=[CH:36][CH:37]=[CH:38][CH:39]=2)[CH2:12][C:13]2[CH:21]=[CH:20][C:19]([O:23][CH2:24][C:25]([OH:27])=[O:26])=[C:18]3[C:14]=2[CH:15]=[N:16][NH:17]3)(=[O:9])=[O:8])[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=1Participants
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
{4-[2-Benzenesulfonylamino-2-(4-phenyl-butylcarbamoyl)-ethyl]-6-chloro-1H-indazol-7-yloxy}-acetic acid (8.0 mg, 0.014 mmol) is dissolved in MeOH (1.5 mL) and 10% Pd/C (5 mg) is added. The reaction is purged with N2 and then with H2. The reaction is rapidly stirred and monitored by HPLC until complete (approximately 30 h). The reaction is filtered through celite and washed with MeOH to provide {4-[2-benzenesulfonylamino-2-(4-phenyl-butylcarbamoyl)-ethyl]-1H-indazol-7-yloxy}-acetic acid. 1H NMR (500 MHz, MeOH-d4) δ 7.88 (s, 1H), 7.49–7.47 (d, 2H), 7.40 (dd, 1H), 7.25–7.21 (m, 4H), 7.15–7.13 (m, 3H), 6.70 (d, 1H), 6.49 (d, 1H), 5.37 (m, 1H), 4.45 (s, 2H), 3.97 (t, 1H), 3.6 (obs, 1H), 3.14 (dd, 1H), 3.07–3.02 (m, 2H), 2.94–2.89 (m, 2H), 2.53 (t, 2H), 1.45–1.39 (m, 2H), 1.28–1.22 (m, 2H); MS (ESI+) m/z 551 (M+H).
Workup
- customThe reaction is purged with N2
- custommonitored by HPLC until complete (approximately 30 h)
- filtrationThe reaction is filtered through celite
- washwashed with MeOH
Sources & evidence
- ORD record
- ord-07c91a5812cd47a1a871308ec1152428
- Source dataset
- uspto-grants-2006_07
- Patent number
- US07078425B2
Reaction notes
Loading…